Treace Medical Concepts (TMCI) CFO reports 11,547-share tax withholding

Rhea-AI Filing Summary

Treace Medical Concepts, Inc. Chief Financial Officer Mark Hair reported a routine share disposition related to tax withholding. On this Form 4, 11,547 shares of common stock were withheld to cover tax obligations, leaving him with 952,002 shares, including 786,691 restricted stock units.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hair Mark

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	11,547	$0.00	--

Holdings After Transaction: Common Stock — 952,002 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Tax-withheld shares: 11,547 shares Shares held after transaction: 952,002 shares Restricted stock units included: 786,691 RSUs

3 metrics

Tax-withheld shares 11,547 shares Shares delivered to cover tax liability on 2026-04-17

Shares held after transaction 952,002 shares Direct holdings of CFO Mark Hair following transaction

Restricted stock units included 786,691 RSUs RSUs included within the reported ownership position

Key Terms

tax-withholding disposition, restricted stock units, Form 4

3 terms

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition" for 11,547 shares"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

restricted stock units financial

"Footnote states: "Includes 786,691 restricted stock units.""

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 4 regulatory

"INSIDER FILING DATA (Form 4): reported transaction details"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hair Mark

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FLORIDA 32081

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/17/2026		F		11,547	D	$0	952,002(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 786,691 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Mark Hair	04/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did TMCI CFO Mark Hair report?

CFO Mark Hair reported a tax-related share disposition, where 11,547 Treace Medical Concepts (TMCI) common shares were withheld. This represents payment of tax liability using shares, rather than an open-market sale, and is a typical administrative transaction tied to equity compensation.

How many TMCI shares does CFO Mark Hair hold after this Form 4?

After the reported transaction, CFO Mark Hair holds 952,002 Treace Medical Concepts shares directly. This total includes a substantial portion of 786,691 restricted stock units, illustrating that most of his reported position remains in long-term equity-based compensation.

Was the TMCI insider transaction an open-market sale of shares?

No. The transaction is coded “F,” meaning it is a tax-withholding disposition, not an open-market sale. Shares were delivered to satisfy tax obligations connected with equity awards, a common practice that does not represent a discretionary sale into the market.

What does the 11,547-share tax withholding mean for TMCI investors?

The 11,547-share withholding is an administrative step to cover taxes on equity compensation. It slightly reduces the CFO’s reported share count but is routine and does not indicate a change in his overall commitment, given remaining holdings of 952,002 shares.

What are the restricted stock units mentioned in the TMCI filing?

The filing notes that CFO Mark Hair’s holdings include 786,691 restricted stock units. Restricted stock units are share-based awards that typically vest over time, aligning executive compensation with company performance and encouraging longer-term ownership in Treace Medical Concepts.